Dr.Evidence Introduces max.ai

Dr.Evidence, the preeminent landscape intelligence platform for life sciences, has introduced max (Maximized Answers eXpedited), to demonstrate our commitment to generating dramatic efficiencies and accuracy in landscape intelligence. In April 2025, we launched max.ai, our proprietary Generative AI (Large Language) model built by the Dr.Evidence team. The model is trained exclusively on our corpus of high-quality, contemporary life sciences data versus the open internet. You’ll experience no IP leakage since none of your queries or data ever leave the security of Dr.Evidence, there’s no waiting in line with requests to large vendors not focused on life sciences, and the model is applied to a robust, expansive ontology to ensure the most relevant answers to your questions. Experience accelerated time-to-market, as you gain dramatic efficiencies by letting our proprietary and accurate AI (max.ai plus over 25 large language, machine learning, and natural language processing models) streamline workflows and eliminate routine tasks. Take advantage of a 360-degree view of the landscape, to strategize based on 550k approved drug labels from 9 major health authorities, 120k FDA and EMA approval packages, 4k FDA and EMA guidance documents, 47k Orange and Purple book data points, 1 million clinical trials, 70 million scientific literature citations, 400k congresses, 31million patents, 500k NIH grands and over 2.1 million articles from healthcare RSS feeds. Break down silos and increase collaboration by leveraging a reliable and central source of truth across the organization. Access the right evidence at the right time, with automated notifications when market dynamics change.